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Summary 
Background Targeted obesity prevention policies would benefit from the identification of population groups with the 
highest risk of weight gain. The relative importance of adult age, sex, ethnicity, geographical region, and degree of 
social deprivation on weight gain is not known. We aimed to identify high-risk groups for changes in weight and BMI 
using electronic health records (EHR).
Methods In this longitudinal, population-based cohort study we used linked EHR data from 400 primary care practices 
(via the Clinical Practice Research Datalink) in England, accessed via the CALIBER programme. Eligible participants 
were aged 18–74 years, were registered at a general practice clinic, and had BMI and weight measurements recorded 
between Jan 1, 1998, and June 30, 2016, during the period when they had eligible linked data with at least 1 year of 
follow-up time. We calculated longitudinal changes in BMI over 1, 5, and 10 years, and investigated the absolute risk 
and odds ratios (ORs) of transitioning between BMI categories (underweight, normal weight, overweight, obesity 
class 1 and 2, and severe obesity [class 3]), as defined by WHO. The associations of demographic factors with BMI 
transitions were estimated by use of logistic regression analysis, adjusting for baseline BMI, family history of 
cardiovascular disease, use of diuretics, and prevalent chronic conditions.
Findings We included 2 092 260 eligible individuals with more than 9 million BMI measurements in our study. Young 
adult age was the strongest risk factor for weight gain at 1, 5, and 10 years of follow-up. Compared with the oldest age 
group (65–74 years), adults in the youngest age group (18–24 years) had the highest OR (4·22 [95% CI 3·86–4·62]) 
and greatest absolute risk (37% vs 24%) of transitioning from normal weight to overweight or obesity at 10 years. 
Likewise, adults in the youngest age group with overweight or obesity at baseline were also at highest risk to transition 
to a higher BMI category; OR 4·60 (4·06–5·22) and absolute risk (42% vs 18%) of transitioning from overweight to 
class 1 and 2 obesity, and OR 5·87 (5·23–6·59) and absolute risk (22% vs 5%) of transitioning from class 1 and 2 
obesity to class 3 obesity. Other demographic factors were consistently less strongly associated with these transitions; 
for example, the OR of transitioning from normal weight to overweight or obesity in people living in the most socially 
deprived versus least deprived areas was 1·23 (1·18–1·27), for men versus women was 1·12 (1·08–1·16), and for Black 
individuals versus White individuals was 1·13 (1·04–1·24). We provide an open access online risk calculator, and 
present high-resolution obesity risk charts over a 1-year, 5-year, and 10-year follow-up period. 
Interpretation A radical shift in policy is required to focus on individuals at the highest risk of weight gain (ie, young 
adults aged 18–24 years) for individual-level and population-level prevention of obesity and its long-term consequences 
for health and health care.
Funding The British Hearth Foundation, Health Data Research UK, the UK Medical Research Council, and the 
National Institute for Health Research.
Copyright © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license
Introduction 
Adult obesity prevention policies, which are largely 
untargeted, have had limited success globally,1,2 and the 
high prevalence of obesity is predicted to increase 
substantially over the next decade.3,4 Population-wide 
approaches to obesity prevention could be complemented 
by new targeted approaches if population groups with 
the highest risk of weight gain could be identified using 
readily available information in national public health 
systems.1 Current obesity prevention policies are 
informed by evidence from cross-sectional, population-
based surveys,5 which, by definition, cannot evaluate 
weight changes, and highlight the increased cross-
sectional prevalence of obesity in middle-aged individuals 
(ie, those aged 40–59 years), those residing in socially 
deprived areas, and in particular ethnic groups.6 In 
longitudinal research, younger adults have been shown 
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to have a greater risk of weight gain than older adults in 
many,7–9 but not all, studies (appendix pp 3–4).10
An emerging data science opportunity to identify 
population groups at high risk for weight gain comes from 
longitudinal population-based electronic health records 
(EHRs). Understanding how adult age, sex, ethnicity, 
geographical region, and degree of social deprivation 
might together influence the risk of weight changes to 
identify groups at highest risk of weight gain is essential if 
targeted policies are to be considered. We found no 
previous studies providing such evidence. Population-
based EHRs offer valid measurements of weight and BMI 
changes,11 and they have potential advantages (compared 
with consented cohort studies) of sufficient scale to 
evaluate the joint contribution of several factors, and of 
providing updatable and low-cost measurements.
We used population-based EHRs to address long-
standing calls for monitoring basic population weight 
data12 in the context of weight change by presenting 
intra-individual 1-year, 5-year, and 10-year patterns in BMI 
changes, according to sociodemographic factors, with the 
following objectives: (1) to test the extent to which 
temporal trends in mean BMI changes between 1998 and 
2016 are replicated between EHRs and survey methods;13 
(2) to compare the extent and distribution of BMI changes 
across age groups and BMI categories; (3) to estimate the 
associations between age, sex, degree of social deprivation, 
ethnicity, and geographical region with transitions across 
BMI categories; and (4) to produce a risk calculator (both 
online and in chart-form), showing how these risk factors 
combine to identify groups at a high risk of transitioning 
to higher BMI categories.
Methods 
Study design and participants 
In this longitudinal, population-based cohort study, we 
used clinically recorded measures of height, weight, and 
BMI from primary care practices in England, accessed 
Research in context
Evidence before this study
Adult obesity prevention policies have had limited success 
globally, and have thus far not sought to identify and target 
groups in the population who have the highest risk of weight 
gain, including those of a normal weight (ie, a BMI of 
18·5–24·9 kg/m²), overweight (ie, a BMI of 25·0–29·9 kg/m²), 
and obesity (ie, a BMI of ≥30·0 kg/m²). We searched PubMed on 
Dec 20, 2020, using the search string “(weight[Title])” OR 
“(body mass index[Title])” AND “(change)”. We searched for 
longitudinal population-based studies of intra-individual 
weight and BMI changes according to age and other 
demographic factors published between Jan 1, 2000, 
and Dec 20, 2020. We found 18 studies involving population-
based cohorts of intra-individual BMI changes in adults in 
studies with sufficiently large sample size (at least 
5000 participants in total, and at least 1000 young adults; 
appendix pp 2–3). Young adult age was shown in some, but not 
all studies to be associated with the highest increase in weight 
and BMI when compared with older ages. Other studies 
suggested separate roles for the effects of ethnicity and sex on 
increases in weight or BMI. However, these previous studies 
were too small or did not contain the necessary information to 
assess multiple risk factors. We found three policy-relevant gaps 
in the knowledge. First, how to identify population groups at 
highest risk of weight gain is not known; we found no study of 
BMI changes that evaluated the combined contribution of 
initial BMI and four important sociodemographic factors (age, 
sex, socioeconomic status, and ethnicity). Second, we found no 
previous study evaluating policy-relevant measures of absolute 
risk of transitioning between normal weight, overweight, 
and obesity BMI categories; instead, previous studies have 
reported continuous measures. Finally, we found no previous 
study that used large-scale data from electronic health records 
(EHRs) in the general population to study patterns of weight 
change in people of a normal weight, or in those with 
overweight or obesity. We found publications supporting the 
validity of using EHRs to study weight changes among people 
with obesity or after bariatric surgery.
Added value of this study
We address these three policy-relevant knowledge gaps. First, 
we show that young adults (aged 18–24 years) had a markedly 
greater risk for transitioning to higher BMI categories than did 
older age groups (ie, those aged 65–74 years). Compared with 
age, we found smaller additional contributions to the risk of 
BMI change, including being male, living in socially deprived 
neighbourhoods, and being from a Black ethnic background. 
Second, in by far the largest study done to date (involving more 
than two million individuals), we provide high-resolution 
estimates of BMI change across 900 strata defined by age 
(six groups), sex (two groups), degree of social deprivation 
(five groups), and initial BMI (15 categories). We provide the 
first estimates of the risks of transitioning between 
underweight, normal weight, overweight, and obesity BMI 
categories at 1, 5, and 10 years (risk charts and an online tool). 
Finally, we show the value of using longitudinal population-
based EHRs to identify and monitor specific population groups 
at risk of weight gain. Health records offer advantages of being 
large scale, low cost, and updatable, and of providing policy-
relevant insights.
Implications of all the available evidence
A radical shift in policy is required to focus on individuals at 
highest risk of weight gain (ie, young adults) for individual and 
population-level prevention of obesity and its long-term 
consequences for health and health care. Particular opportunities 
for intervention might arise as young adults transition away from 
living at home, or into education, relationships, and work.
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through the Clinical Practice Research Datalink. This 
study was done as part of the CALIBER research 
platform). CALIBER, led by the UCL Institute of Health 
Informatics (University College London, London, UK), is 
an open resource for researchers providing validated 
EHR phenotyping algorithms and tools for the use of 
national structured health record data sources. Through 
the CALIBER platform,13 we obtained data from 
individuals aged 18–74 years registered at 400 primary 
care practices in England, with BMI measurements 
recorded between Jan 1, 1998, and June 30, 2016 (see 
appendix pp 5–8).
The study was approved by the UK Medicines and 
Healthcare products Regulatory Agency Independent 
Scientific Advisory Committee (18_010R), under Section 
251 of the National Health Service (NHS) Social Care 
Act 2006, for the use of anonymised records in research 
without individual participant written consent. 
Data collection 
NHS policy is for a patient’s weight and height to be 
recorded at registration with a general practice clinic, 
with these measurements repeated at health checks 
(currently offered to patients aged 40–74 years and done 
once every 5 years) and at clinical discretion.11 We 
extracted height (in m), weight (in kg) and BMI (in kg/m²) 
measurements, as recorded during usual care by 
physicians, nurses, and health-care assistants using a 
range of devices. We included individuals with BMI and 
weight measurements recorded during the period in 
which they had eligible linked data, with at least 1 year of 
follow-up. We excluded individuals with BMI recorded 
during pregnancy; who had BMI measurements taken 
on the same day that differed by more than 0·5 kg/m²; 
whose highest recorded BMI was more than double their 
lowest recorded BMI; and in whom the absolute 
difference between recorded and calculated BMI on the 
Figure 1: Flow chart showing the number of individuals and BMI measurements recorded in EHRs used for calculating 1-year, 5-year, and 10-year changes 
in BMI
EHR=electronic health record. *Temporal trends in BMI were calculated and compared with HSE data (see appendix pp 6–7). †For people with more than one valid 
pair of BMI measurements, we chose one pair at random for the calculation of BMI change. ‡We excluded individuals with a follow-up interval since their initial BMI 
measurement of less than half the time window of interest (ie, <6 months for estimating 1-year BMI changes, 2·5 years for estimating 5-year BMI changes, 
and 5 years for estimating 10-year BMI changes). §We selected one timepoint with a BMI measurement at random and applied multiple imputation analysis. 
236 187 aged ≥75 years excluded
2 396 540 individuals with linked EHR data and 
 at least one BMI and weight measurement 
 between 1998 and 2016 in England 
2 328 447 with >1 valid BMI measurement 
 (11 187 383 BMI measurements)*
2 092 260 aged 18–74 years included 
 (9 258 545 BMI measurements)
68 093 excluded
 64 909 had BMI measured during pregnancy
 610 had BMI measurements taken on the 
 same day that differed by >0·5 kg/m²
 2253 had BMI measurements recorded and 
 calculated on the same day that 
 differed by >1 kg/m² 
 321 in  whom their highest recorded BMI 
 was more than double their lowest 
 recorded BMI 
BMI change at 1 year (time window 6 months to 
2 years)†
1 001 872 included in the assessment of
 BMI change 
910 717 had missing values
179 671 died or were lost to follow-up‡
1 912 589 included after multiple 
 imputation
BMI change at 5 years (time window 4–6 years)†
735 754 included in the assessment of BMI change 
788 268 had missing values
568 238 died or were lost to follow-up‡
1 524 022 included after multiple imputation
BMI change at 10 years (time window
8–12 years)†
457 506 included in the assessment of 
 BMI change 
659 818 had missing values
974 936 died or were lost to follow-up‡
1 117 324 included after multiple 
 imputation
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same day was more than 1 kg/m² (figure 1). Following 
WHO guidelines, we defined underweight as a BMI of 
less than 18·5 kg/m²; normal weight as a BMI of 
18·5–24·9 kg/m²; overweight as a BMI of 
25·0–29·9 kg/m²; non-severe obesity (class 1 and 2) as a 
BMI of 30·0–39·9 kg/m²; and severe obesity (class 3) as 
a BMI of 40 kg/m² or higher.
We grouped individuals by age (taken at the date of the 
first BMI measurement; 18–24 years, 25–34 years, 
35–44 years, 45–54 years, 55–64 years, and 65–74 years); 
sex (male or female); ethnicity (White, Asian [Chinese, 
Indian, Pakistani, Bangladeshi, or other Asian ethnicity], 
Black [Black African, Black Caribbean, or other Black 
ethnicity], or mixed or other ethnicity); degree of social 
deprivation, measured by use of the region-based Index 
of Multiple Deprivation (IMD; in quintiles from least 
deprived [first quintile] to most deprived [fifth quintile]); 
and geographical region (London, South West England, 
South Central England, South East England, West 
Midlands, East of England, central North East England, 
and North West England). Data on chronic disease, 
smoking status, and physical activity were also extracted 
from EHRs.
Statistical analysis 
To compare trends in mean BMI changes over time, we 
randomly selected one BMI measurement from all 
eligible individuals included in CALIBER, and compared 
mean BMI between 1998 and 2016 in England with 
standardised survey measures of BMI from an annual 
cross-sectional survey (the Health Survey for England 
[HSE]), according to age and sex.14 The HSE is a source of 
data, independent of health-care consultation and 
recording practices, that has been widely used to inform 
public policy. We also compared EHR measures of BMI 
with corresponding measures obtained from the US 
National Health and Nutrition Examination Survey 
(NHANES)15 over the same time period, according to age 
group. 
To estimate 1-year, 5-year, and 10-year changes in BMI, 
we randomly selected one pair of BMI measurements 
from individuals who had measurements taken during 
time windows of 6 months to 2 years, 4 years to 6 years, 
and 8 years to 12 years, respectively. We assumed that any 
change in BMI for each patient was linear during each 
time window (appendix pp 10–12).
The problem of missing values arises because not all 
individuals had two BMI measurements within the 
specific time windows of interest (figure 1). We assumed 
that the missingness mechanism for BMI change was 
missing not at random. For this reason, we applied 
multiple imputation with delta-adjustment, as this 
method provides a flexible and transparent means to 
impute missing data under missing-not-at-random 
mechanisms.16 We first imputed the missing values, not 
only for BMI change, but also for other factors using 
multiple imputation by chained equations (MICE). 
Specifically, we created ten copies of datasets in which 
missing values for BMI change, ethnicity, IMD, 
smoking status, and physical activity were replaced by 
imputed values sampled from their predictive 
1-year BMI change 
(n=1 912 589)
5-year BMI change 
(n=1 524 022)
10-year BMI change 
(n=1 117 324)
Sex
Female 1 096 689 (57%) 872 394 (57%) 646 392 (58%)
Male 815 900 (43%) 651 628 (43%) 470 932 (42%)
Age, years 46·9 (15·5) 47·2 (15·2) 47·4 (14·8)
18–24 187 574 (10%) 140 510 (9%) 92 779 (8%)
25–34 289 098 (15%) 210 433 (14%) 146 443 (13%)
35–44 360 589 (19%) 300 878 (20%) 231 871 (21%)
45–54 399 105 (21%) 327 372 (21%) 249 941 (22%)
55–64 365 952 (19%) 305 205 (20%) 231 382 (21%)
65–74 310 271 (16%) 239 624 (16%) 164 908 (15%)
BMI, kg/m² 27·3 (5·9) 27·3 (5·7) 27·3 (5·6)
Distribution of BMI categories at baseline in the 18–24 years age group* 
Underweight 14 251 (8%) 10 476 (7%) 6740 (7%)
Normal weight 104 643 (56%) 78 376 (56%) 52 040 (56%)
Overweight 39 322 (21%) 29 751 (21%) 19 667 (21%)
Obesity 29 358 (16%) 21 907 (16%) 14 332 (15%)
Distribution of BMI categories at baseline in the 25–34 years age group*
Underweight 9481 (3%) 6466 (3%) 4333 (3%)
Normal weight 135  794 (47%) 97 535 (46%) 67 168 (46%)
Overweight 80 481 (28%) 59 919 (28%) 42 046 (29%)
Obesity 63 342 (22%) 46 513 (22%) 32 896 (22%)
Distribution of BMI categories at baseline in the 35–44 years age group*
Underweight 5619 (2%) 4402 (1%) 3359 (1%)
Normal weight 131 898 (37%) 110 404 (37%) 86 130 (37%)
Overweight 121 598 (34%) 102 260 (34%) 78 455 (34%)
Obesity 101 474 (28%) 83 812 (28%) 63 927 (28%)
Distribution of BMI categories at baseline in the 45–54-years age group*
Underweight 4654 (1%) 3607 (1%) 2636 (1%)
Normal weight 122 093 (31%) 101 413 (31%) 78 676 (31%)
Overweight 146 696 (37%) 121 306 (37%) 93 598 (37%)
Obesity 125 662 (31%) 101 046 (31%) 75 031 (30%)
Distribution of BMI categories at baseline in the 55–64-years age group*
Underweight 4603 (1%) 3248 (1%) 2223 (1%)
Normal weight 103 161 (28%) 87 055 (29%) 67 353 (29%)
Overweight 142 108 (39%) 121 086 (40%) 93 726 (41%)
Obesity 116 080 (32%) 93 816 (31%) 68 080 (29%)
Distribution of BMI categories at baseline in the 65–74-years age group*
Underweight 5321 (2%) 3208 (1%) 1798 (1%)
Normal weight 91 674 (30%) 70 856 (30%) 49 000 (30%)
Overweight 125 115 (40%) 99 644 (42%) 70 734 (43%)
Obesity 88 161 (28%) 65 916 (28%) 43 376 (26%)
Ethnicity
White 1 405 432 (73%) 1 140 068 (75%) 848 231 (76%)
Black 61 132 (3%) 44 426 (3%) 29 786 (3%)
Asian 36 260 (2%) 25 418 (2%) 14 893 (1%)
Mixed or other 23 339 (1%) 16 235 (1%) 10 208 (1%)
Missing 386 426 (20%) 297 875 (20%) 214 206 (19%)
(Table continues on next page)
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distribution by use of MICE, which was applied 
separately for the six age groups. We then added delta 
values to our imputed datasets of BMI change to 
minimise any bias due to missingness not at random. 
After implementation of this approach, the average 
10-year BMI change according to age and sex in our 
study (using CALIBER) and the HSE were the same. 
More details of the methods used to account for missing 
data are in the appendix (pp 13–19).
For sociodemographic factors, we estimated the odds 
ratios (ORs) for transitioning between BMI categories 
over 1-year, 5-year, and 10-year periods using of logistic 
regression models. For example, to estimate the ORs 
for transitioning from overweight to obesity BMI 
categories, logistic regression was used whereby the 
dependent variable was “0” for individuals who did not 
transition and “1” for those who did transition 
(appendix pp 20–23). In all of these models, we 
additionally adjusted for BMI at baseline, a family 
history of cardiovascular disease, use of diuretics, 
prevalent cardiovascular disease, cancer, diabetes, 
mental health disorders (depression, anxiety, stress, 
phobia, schizophrenia, bipolar disorder, or affective 
disorder), and other prevalent chronic conditions (HIV, 
chronic obstructive pulmonary disease, neurological 
disease [dementia], rheumatological disease [rheu-
matoid arthritis, gout, or systemic lupus erythema-
tosus], gastro intestinal disease [inflammatory bowel 
disease], or renal disease [chronic kidney disease or 
renal failure]) at baseline.
We calculated the age-standardised transition between 
BMI categories at 1, 5, and 10 years on the basis of the 
age structure of the English population (Office for 
National Statistics) and BMI information from the HSE 
(appendix p 24). We produced risk charts estimating the 
BMI changes at 10 years by age, IMD, and initial BMI, as 
well as separately for men and women non-
parametrically. We also created an online risk calculator 
(appendix p 25).
Role of the funding source 
The funders of the study had no role in study design, 
data collection, data analysis, data interpretation, or 
writing of the report.
Results 
We identified 2 396 540 individuals with linked EHR data 
and at least one BMI measurement recorded 
between 1998 and 2016 in England, of whom 
2 092 260 individuals aged 18–74 years with at least one 
valid BMI measurement were included in the analysis 
(figure 1). The baseline characteristics of all individuals at 
the time of their first BMI measurements are provided in 
the table. Regarding the individuals contributing to the 
assessment of 10-year BMI changes, the proportion of 
women (646 392 [58%]) was higher than men 
(470 932 [42%]). Most individuals were White (848 231 
[76%]), 99 502 (9%) had prevalent cardiovascular disease, 
and 44 625 (4%) had prevalent cancer.
We first validated time trends in mean BMI changes 
using EHR (CALIBER) data compared with HSE data. 
Minor differences between mean BMI estimates obtained 
from EHR and HSE were observed, particularly in 
individuals aged younger than 65 years (appendix pp 6–7). 
Mean BMI was higher in older age groups than in younger 
age groups. We then compared time trends in mean BMI 
changes using CALIBER with those from US NHANES 
data. Mean BMI increased in each age group between 1999 
and 2016 in England, and the rate of increase was similar 
to that observed in the USA, with mean BMIs in the USA 
approximately 2 kg/m² higher in each biannual period 
and age group compared with England (appendix p 8). 
Using EHR data, we estimated the initial and estimated 
average weight at 10 years according to age and sex 
(appendix p 28). We found that younger individuals 
gained more weight on average than older individuals 
during this time period. For example, the average initial 
weight in men aged 18–24 years was 80·8 kg, and their 
average estimated weight after 10 years was 90·2 kg, 
whereas the average initial weight of men aged 
65–74 years was 83·9 kg, and their average estimated 
weight after 10 years was 82·2 kg.
Adults in the youngest age group (18–24 years) had the 
highest increase in weight at 10 years, and the widest 
1-year BMI change 
(n=1 912 589)
5-year BMI change 
(n=1 524 022)
10-year BMI change 
(n=1 117 324)
(Continued from previous page)
Index of Multiple Deprivation quintile
1 (least deprived) 317 299 (17%) 261 382 (17%) 198 813 (18%) 
2 311 664 (16%) 254 612 (17%) 190 582 (17%)
3 297 464 (16%) 239 316 (16%) 177 138 (16%)
4 277 168 (14%) 220 613 (14%) 161 415 (14%)
5 (most deprived) 244 600 (13%) 192 236 (13%) 137 042 (12%)
Missing 464 394 (24%) 355 863 (23%) 252 334 (23%)
Family history of cardiovascular 
disease
484 281 (25%) 403 575 (26%) 312 249 (28%)
Use of diuretics 263 253 (14%) 213 835 (14%) 155 597 (14%)
Prevalence of chronic diseases
Cancer 100 838 (5%) 70 018 (5%) 44 625 (4%)
Cardiovascular disease 184 118 (10%) 141 533 (9%) 99 502 (9%)
Diabetes 139 737 (7%) 101 046 (7%) 66 601 (6%)
Hypertension 902 998 (47%) 723 369 (47%) 527 420 (47%)
Mental health disorders† 580 160 (30%) 433 828 (28%) 298 979 (27%)
Other chronic diseases‡ 200 230 (10%) 140 513 (9%) 86 484 (8%)
Data are n (%) or mean (SD). The table shows baseline characteristics of patients at the time of their first BMI 
measurement (recorded in their health records), which was used to calculate changes in BMI at 1, 5, and 10 years. 
*Percentages are calculated according to the total number of patients in each age group. †Includes depression, anxiety, 
stress, phobia, schizophrenia, bipolar disorder, and affective disorder. ‡Includes chronic obstructive pulmonary 
disease, neurological disease (dementia), rheumatological disease (rheumatoid arthritis, gout, and systemic lupus 
erythematosus), gastrointestinal disease (inflammatory bowel disease), HIV, and renal disease (chronic kidney disease 
and renal failure). 
Table: Baseline characteristics 
For the online BMI and weight 
change risk calculator see bmi.
caliberresearch.org
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Figure 2: Distribution of weight changes at 10 years in men (A) and women (B) by age and BMI category
In A, 470 932 men were included in the analysis; an average height of 1·76 m was assumed. In B, 646 392 women were included in the analysis; an average height of 1·62 m was assumed. 
IDR=interdecile range. p10=10th percentile. p90=90th percentile.
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distribution in each BMI category (figure 2A, B). Each of 
these measures decreased progressively with increasing 
age in each BMI category. For example, in men aged 
18–24 years in the normal weight BMI category, the 
median weight change was 7·9 kg and the 90th percentile 
was 22·0 kg compared with a median weight change of 
0·5 kg and a 90th percentile of 10·7 kg in men aged 
65–74 years (figure 2A). Similar findings were observed 
for 1-year and 5-year weight changes in both men and 
women (appendix p 29).
We estimated that, in the normal weight BMI category, 
13% transitioned to the overweight category at 1 year, 
22% at 5 years, and 29% at 10 years (figure 3). In the 
overweight BMI category, 11% transitioned to the obesity 
category at 1 year, 21% at 5 years, and 29% at 10 years. In 
the obesity BMI category, we estimated that 15% 
transitioned to the overweight category at 1 year, 18% at 
5 years, and 19% at 10 years. 
Compared with adults in the oldest age group 
(65–74 years), adults in the youngest age group 
(18–24 years) had the highest relative risk (OR 4·22 
[95% CI 3·86–4·62]) and absolute risk (37% vs 24%) of 
transitioning from the normal weight BMI category to 
overweight or obesity categories at 10 years (figure 4). 
Other demographic factors, such as degree of social 
deprivation (most deprived vs least deprived OR 1·23 
[1·18–1·27]), sex (men vs women OR 1·12 [1·08–1·16]) 
and ethnicity (Black individuals vs White individuals 
OR 1·13 [1·04–1·24]), were less associated with this 
transition. Compared with the 65–74 years age group, 
individuals in the 18–24 years age group had the highest 
relative risk (OR 4·60 [4·06–5·22]) and absolute risk 
(42% vs 18%) of transitioning from the overweight to the 
obesity BMI category, and the highest relative risk 
(OR 5·87 [5·23–6·59]) and absolute risk (22% vs 5%) of 
transitioning from class 1 and 2 obesity to class 3 obesity. 
We found that the association between IMD and 
transition to a higher BMI category was even more 
pronounced among individuals in the 18–24 years age 
group compared with older age groups (appendix p 30).
We also considered the absolute and relative risks of 
transitioning from normal weight to underweight BMI 
categories and for remaining in the obesity BMI category 
over the 10-year period. Compared with the other age 
groups, individuals in the 65–74 years age group had a 
higher risk of transitioning from normal weight to 
underweight BMI categories (appendix p 31). We also 
observed that individuals aged 35–54 years had the highest 
absolute risk (84% in the 35–44 years age group and 
83% in the 45–54 years age group) and OR (35–44 years vs 
65–74 years OR 2·09 [95% CI 1·97–2·22]; 45–54 years vs 
65–74 years 1·97 [1·87–2·08]) of remaining in the obesity 
BMI category at 10 years. We observed similar results for 
the youngest age group for the transitions at higher BMI 
categories at 1 and 5 years (appendix pp 32–33).
We next developed the risk calculator for estimating the 
risk of transitioning between BMI categories, combining 
Figure 3: Estimated age-standardised risk of transitioning to normal weight 
(A), overweight (B), and obesity (C) according to BMI category at 1, 5, 
and 10 years of follow-up
The risk of transitioning was standardised to the English population based on 
age structure (using information from Office of National Statistics) and 
prevalence of BMI categories (using data from the Health Survey for England) 
between 1998 and 2016. For a detailed description of the methods used for this 
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age, sex, degree of social deprivation, and initial BMI. We 
show that, within each stratum, the risks for transitioning 
to higher BMI categories were substantially higher in the 
youngest adult age group than in older age groups. For 
example, compared with men aged 65–74 years in the third 
IMD quintile who were close to the BMI transition cutoffs, 
the risk of those aged 18–24 years transitioning from the 
normal weight to the overweight BMI category at 10 years 
was 68% versus 44%, from the overweight to the obesity 
BMI category was 65% versus 38%, and from the class 1 
and 2 obesity to class 3 obesity BMI category was 
47% versus 27% (figure 5). By contrast, there were only 
modest modifications of the influence of the risk of 
transitioning to higher BMI categories by degree of social 
deprivation and sex (figure 5; see also the online risk 
calculator). We found consistent patterns of age-associated 
transitions to higher BMI categories at 1 year (appendix p 34) 
and 5 years (appendix p 35).
The sensitivity analyses indicated that our findings 
were robust when we applied the same analysis: 
(1) without controlling for the prevalent chronic 
conditions (appendix p 38); (2) excluding individuals 
with prevalent chronic diseases at baseline 
(appendix p 39); (3) excluding individuals with prevalent 
chronic diseases and those who developed chronic 
conditions during follow-up (appendix p 40); (4) without 
accounting for the delta values after the multiple 
imputation (appendix p 42); and (5) excluding all missing 
values (complete case analysis; appendix p 41). We also 
found that the results remained largely the same in 
individuals who had never smoked, and in former and 
current smokers (appendix p 43). Compared with 
individuals who had never smoked, former smokers had 
a higher risk of transitioning to a higher BMI category, 
whereas current smokers had a lower risk (appendix p 44).
Discussion 
Young adults (aged 18–24 years) have the highest absolute 
and relative risk for transitioning to a higher BMI category 
than older age groups; smaller additional contributions to 
Odds ratio 
(95% CI)
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the risk of BMI changes from living in socially deprived 
regions and ethnicity were also observed. In the largest 
study done to date, we provide the first high-resolution 
obesity risk calculator based on age, sex, degree of social 
deprivation, ethnicity, and current BMI to identify the risk 
of intra-individual changes in BMI and transitioning across 
BMI categories. Our findings show that it is possible to 
identify individuals at the highest risk of weight gain using 
EHRs and information readily available to public health 
agencies, and that young adults should be a major focus of 
strategies to prevent the onset of overweight and obesity.
We did this large-scale study (involving more than 
two million individuals) to provide high-resolution 
estimates of BMI change across 900 strata, defined by 
age (six groups), sex, social deprivation (five groups), 
and initial BMI (15 categories). Most of the individual 
strata contained more than 1000 individuals. 
Approximately 77% of adults have at least one BMI 
measurement recorded in their primary health-care 
record; a percentage that is higher compared with the 
response rates in consented cross-sectional surveys such 
as HSE14 and NHANES.15 For repeated measures, 
completeness for 1-year BMI changes in CALIBER 
improved from 47% before 2005 to 53% from 2006 to 
2016 in our study. Previous studies have shown the 
validity of single measures of BMI recorded in primary 
care,11 and of BMI changes in people with obesity17 or 
after bariatric surgery.18 Our study replicates (and 
extends) previous findings from smaller longitudinal 
studies (appendix pp 3–4) using large-scale EHRs. We 
propose that the monitoring of population weight data 
by public health agencies should involve incorporating 
information on intra-individual weight changes from 
EHRs, which are becoming increasingly available.19,20
Adults in the youngest age group (18–24 years) had the 
highest absolute and relative risk of transitioning from 
the normal weight to overweight or obesity BMI 
categories, from the overweight to obesity BMI categories, 
and from class 1 and 2 obesity to class 3 obesity BMI 
categories at 1, 5, and 10 years. Individuals aged 
35–54 years had the highest risk for remaining in the 
obesity BMI category, further emphasising the 
importance of early intervention.
Our findings have policy implications in three inter-
related areas: (1) obesity prevention; (2) the health 
priorities of young adults; and (3) addressing lockdown-
associated weight gain. First, obesity prevention policies 
should identify groups at a high risk of weight gain for 
targeted interventions. There could be key opportunities 
for intervention in young adults because certain factors, 
such as changes in dietary and exercise behaviours21 and 
relationships,22 being in higher education, and 
employment status,23 can influence weight gain. For 
example, BMI can increase in women and men during 
the course of cohabiting relationships and marriage.22 
Identifying groups at the highest risk of weight gain is 
not currently recommended in obesity prevention 
policies,24 and is not mentioned in reports on new 
strategies in obesity prevention.1 Most of the attention of 
current obesity prevention guidelines is directed mainly 
at individuals who already have obesity.24 As the evidence 
presented in our study suggests, the opportunity to 
modify weight gain is greatest in individuals who are 
young and do not yet have obesity. Our findings also 
suggest that regional and national initiatives aimed at 
socially deprived areas might be complemented by 
targeting young adults. Second, young adults are 
increasingly a focus of health policies seeking to address 
a wide range of issues, including substance abuse, sexual 
health, mental health, violence and injuries, and 
Figure 4: Absolute risk and odds ratio of transitioning from normal weight to overweight or obesity BMI 
categories, from overweight to obesity BMI categories, and from class 1 and 2 obesity to class 3 obesity BMI 
categories at 10 years, according to age, sex, ethnicity, degree of social deprivation, and geographical region 
Odds ratios were mutually adjusted for BMI (at baseline), age group, sex, IMD quintile, ethnicity, geographical 
region, use of diuretics, and the prevalence of cardiovascular disease, cancer, diabetes, hypertension, mental health 
disorders (depression, anxiety, stress, phobia, schizophrenia, bipolar disorder, or affective disorder), and other 
chronic diseases (HIV, chronic obstructive pulmonary disease, neurological disease [dementia], rheumatological 
disease [rheumatoid arthritis, gout, or systemic lupus erythematosus], gastrointestinal disease (inflammatory 
bowel disease), and renal disease [chronic kidney disease or renal failure]). IMD=Index of Multiple Deprivation. 
*Refers to the number of individuals who transitioned to a higher BMI category; for ethnicity and IMD (the two 
variables with missing values), the numbers were calculated from the first imputation.
Odds ratio 
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Figure 5: Absolute risk of 
transitioning to a higher BMI 
category over 10 years, 
according to baseline BMI 
category, age, sex, and IMD 
quintile 
This analysis included 
1 117 324 individuals; across 
the 900 strata, there are at 
least 1000 individuals in 
458 (51%) strata, and at least 
100 individuals in 890 (99%) 
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criminality.21 An extensive review of preventive 
interventions targeted to young adults made no mention 
that this group of individuals are at highest risk of weight 
gain, and found that there were no programmes 
addressing overweight, obesity, or healthy living.25 
Additionally, the increasing trends in BMI are combined 
with an increasing prevalence of diabetes in young 
adults.10 From the perspective of both obesity prevention 
and health in young adults, it is important to address the 
challenge that, with the exception of pregnancy 
complications, most of the adverse health consequences 
of obesity and weight gain (including severe COVID-19, 
cardiovascular disease, and type 2 diabetes)26 occur 
decades later, in middle-age and older age. Finally, 
repeated lockdowns during the COVID-19 pandemic have 
profoundly reduced the amount of physical activity and 
energy expenditure in young adults, which has had 
adverse effects on weight gain.27
Population-based EHRs are the only high-resolution 
source of information on changes in BMI with a 
sufficient sample size to estimate risk across 
combinations of age, sex, ethnicity, degree of social 
deprivation, and BMI category. Our study was the first 
large-scale study to focus on modern BMI change 
patterns at 1, 5, and 10 years at a high resolution, taking 
socioeconomic and demographic factors into considera-
tion.
Our study has important limitations. We focused on 
BMI changes at 1, 5, and 10 years; however, individuals 
had their bodyweight measurements taken at their 
general practice clinic infrequently, and younger (and 
healthier) individuals had their bodyweight 
measurements taken less frequently than older 
indviduals.11 To address this problem, we considered time 
windows within which individuals had a pair of recorded 
BMI measurements, and assumed linear BMI changes 
in these time windows. Despite the large sample size of 
our study, it is possible that our sample was not 
representative for estimating changes in BMI, as the 
individuals who had their bodyweight measured multiple 
times at the general practice clinic had a higher 
prevalence of chronic disease than those with one or no 
measurement. A challenge to any study investigating 
long-term BMI changes is loss to follow-up; the 
proportion of missing pairs of BMI observations was 
48% in the 1-year time window, 52% in the 5-year time 
window, and 59% in the 10-year time window, comprising 
individuals who had died or were no longer registered 
with their general practice. To account for this limitation, 
we applied multiple imputation with delta-adjustment 
(to account for missingness not at random)16 using mean 
BMI change data from the HSE. Our results were robust 
to sensitivity analyses using a complete case analysis (no 
imputation of missing values) and without delta 
adjustment. However, we cannot exclude the possibility 
that we mis-specified the imputation models, even 
though it is unlikely that the resulting bias would be 
major. In addition, because we used observational data, it 
is possible that some of the health variables we used, 
both in the imputation model and in the analysis 
presented in figure 4, were prone to misclassification 
bias. Furthermore, since a small proportion of people 
aged 18 years had not attained their adult height,28 BMI 
changes in a small proportion of individuals in the 
youngest age group might have been slightly 
underestimated. Comparing data from CALIBER and the 
HSE, mean BMI values according to age, sex, and 
calendar year were not significantly different in adults 
aged 18–54 years (ie, the 95% CIs included 0). However, 
among individuals aged 65–74 years there was some 
evidence that BMI measurements from the HSE were 
higher than those from CALIBER (appendix p 7); 
nevertheless, we included age in the imputation models, 
and we applied the delta-adjustment to correct any 
remaining (small) differences at the end.
Our findings suggest the importance of appropriate 
interventions for obesity prevention at both population 
and individual levels. At the population level, structural 
mechanisms (eg, access to housing, affordable healthy 
food choices, and physical activity opportunities) might 
influence the risk of transitioning to the obesity BMI 
category in young adults. There is a need to develop 
interventions targeted at groups of individuals who have 
the highest risk of weight gain, with the aim of achieving 
weight maintenance in the normal weight BMI category. 
Given the projected weight gain in children and 
adolescents, complementary approaches before and after 
the age of 18 years should be followed.29 At the individual 
level, is it possible to communicate information on risk 
of weight gain, and incorporate this information into 
interventions designed to affect the knowledge, attitude, 
and behaviour of young adults? Individuals might have, 
or seek, additional and actionable predictive information 
(eg, accelerometery data), which could inform the design 
of interventions. In addition, to what extent is there a role 
for primary care professionals30 and other clinicians in 
using and recording risk of weight gain information 
alongside other actionable information in the EHR?
In summary, we found that young adults aged 
18–24 years had the highest risk of transitioning to a 
higher BMI category compared with older age groups. 
Compared with age, other sociodemographic factors had 
weaker absolute and relative associations with weight 
gain and transitioning to higher BMI categories. Young 
adulthood offers an important, and currently neglected, 
opportunity for both population-level prevention of the 
onset of obesity and the identification of individuals at 
high risk of weight gain for targeted interventions.
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